Nature Reviews Cancer
@natrevcancer.nature.com did:plc:dn6fixr3gc5fqz6uqotfmesh
Nature Reviews Cancer is a monthly review journal for researchers working on cancer. We, the editors, highlight the most exciting topics in cancer research. https://www.nature.com/nrc/
En Bluesky desde el
- Seguidores
- 6.171
- Siguiendo
- 744
- Posts
- 531
- Días en rankings
- 0
Resumen
Nature Reviews Cancer (@natrevcancer.nature.com) es un usuario de Bluesky que se unió el 19 noviembre 2024. Tiene 6.171 seguidores, sigue a 744 cuentas y ha publicado 531 posts.
Apariciones en rankings
Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.
Esta cuenta aún no ha aparecido en un ranking diario.
Posts que le gustaron recientemente
Me gusta públicos de la red Bluesky.
Registration and abstract submissions are now open for Next Generation Cancer Therapeutics. This Nature Conference will bring together leading global researchers who are transforming the landscape of cancer therapies for discussions and networking. go.nature.com/4eHSlnc #STEMConference
Ver postCongratulations @belindaparker.bsky.social and collaborators on the new @natrevcancer.nature.com release! 🤩 They summarize the regulation and function of type I IFNs in cancer, with a focus on tumor-intrinsic mechanisms controlling canonical and chronic signaling. 🔗 https://go.nature.com/3PqzXVh
Ver post📰 Proud to be featured in Nature Reviews Cancer The article highlights the growing recognition of microbiota-centered interventions as a promising avenue to improve outcomes in acute GvHD and allo-HCT. 👉 Read the full article: www.nature.com/articles/s41... @nature.com @natrevcancer.nature.com
Ver post🚨📖🎗️⬇️
Ver postSo happy to see that the team’s tour de force sparked interest!!! Hope it’s informative and inspires more people to study #agingandcancer Melissa Dolan Kendra Libby Alison Ringel @vangalenlab.bsky.social
Ver post
Cuentas que bloquea
En Bluesky los bloqueos son registros públicos.
Esta cuenta no bloquea a nadie.